Paper · 28024947

Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.

Sireci AN and 5 others. J Mol Diagn, 2017. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement. Papers, record 28024947. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28024947

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.; PubMed
Journal: J Mol Diagn; PubMed
Year: 2017; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/28024947/; PubMed
DOI: https://doi.org/10.1016/j.jmoldx.2016.10.008; PubMed
The journal: https://conductscience.org/library/journal-index/100893612; PubMed
Citations, by iCite: 27; iCite
Relative citation ratio, by iCite: 0.97; iCite
Revised in PubMed: 2018-01-22; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Sireci AN	Anthony N
2	Aggarwal VS	Vimla S
3	Turk AT	Andrew T
4	Gindin T	Tatyana
5	Mansukhani MM	Mahesh M
6	Hsiao SJ	Susan J

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Academic Medical Centers	Major topic
Cancer Care Facilities	Major topic
Gene Expression Profiling	Major topic
Genetic Testing	Major topic
Genomics	Major topic
Neoplasms	Major topic
Biomarkers, Tumor
DNA Mutational Analysis
Genetic Variation
Humans
Insurance, Health, Reimbursement
Mutation
Reproducibility of Results
Sensitivity and Specificity
Time Factors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMID	Title	Journal	Year	In Papers	Source
41,759,531	Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.	Cell Rep Med	2026	https://conductscience.org/library/papers/41759531	PubMed
41,315,957	Mass spectrometry-based proteomics of FFPE tissues: progress, limitations, and clinical translation barriers.	Clin Proteomics	2025	https://conductscience.org/library/papers/41315957	PubMed
39,269,310	Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.	Clin Cancer Res	2024	https://conductscience.org/library/papers/39269310	PubMed
37,561,981	The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.	JCO Precis Oncol	2023	https://conductscience.org/library/papers/37561981	PubMed
37,148,308	Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.	Cancer Control	2023	https://conductscience.org/library/papers/37148308	PubMed
36,454,130	Toward a More Just System of Care in Molecular Pathology.	Milbank Q	2022	https://conductscience.org/library/papers/36454130	PubMed
35,855,114	Pineal region ganglioglioma: A neoplasm with a bimodal age distribution.	Surg Neurol Int	2022	https://conductscience.org/library/papers/35855114	PubMed
35,368,231	Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.	Appl Health Econ Health Policy	2022	https://conductscience.org/library/papers/35368231	PubMed
32,375,398	Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice.	Cancers (Basel)	2020	https://conductscience.org/library/papers/32375398	PubMed
31,835,848	Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma.	Cancers (Basel)	2019	https://conductscience.org/library/papers/31835848	PubMed

1 to 10 of 16

See all 16 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28024947

GET https://conductscience.org/api/papers/v1/28024947/authors

API reference For AI assistants